Use of depot medroxyprogesterone acetate and fracture risk

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 11, 2010, Pages 4909-4916

  Meier, Christian ^a   Brauchli, Yolanda B ^b   Jick, Susan S ^a,c   Kraenzlin, Marius E ^a   Meier, Christoph R ^a,b,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CALCANEUS FRACTURE; CASE CONTROL STUDY; CLAVICLE FRACTURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FACTUAL DATABASE; FEMALE; FEMUR FRACTURE; FINGER FRACTURE; FOREARM FRACTURE; FRACTURE; FRAGILITY FRACTURE; HAND FRACTURE; HIP FRACTURE; HORMONAL CONTRACEPTION; HUMAN; LEG FRACTURE; MAJOR CLINICAL STUDY; PATELLA FRACTURE; PRIORITY JOURNAL; RIB FRACTURE; RISK FACTOR; SPINE FRACTURE; TREATMENT DURATION;

EID: 78049526466     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0032     Document Type: Article

References (41)

1. Sambrook P, Cooper C 2006 Osteoporosis. Lancet 367:2010-2018
2. Kaunitz AM, Rosenfield A 1993 Injectable contraception with depot medroxyprogesterone acetate. Current status. Drugs 45:857-865 (Pubitemid 23219069)
3. Cromer BA, Berg-Kelly KS, Van Groningen JP, Seimer BS, Ruusuvaara L 1998 Depot medroxyprogesterone acetate (Depo-Provera) and levonorgestrel (Norplant) use in adolescents among clinicians in Northern Europe and the United States. J Adolesc Health 23:74-80
4. Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM 1995 Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives. Contraception 51:149-153
5. Cromer BA, Scholes D, Berenson A, Cundy T, Clark MK, Kaunitz AM 2006 Depot medroxyprogesterone acetate and bone mineral density in adolescents-the Black Box Warning: a Position Paper of the Society for Adolescent Medicine. J Adolesc Health 39:296-301
6. Lopez LM, Grimes DA, Schulz KF, Curtis KM 2009 Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev 15:CD006033
7. Ott SM, Scholes D, LaCroix AZ, Ichikawa LE, Yoshida CK, Barlow WE 2001 Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab 86:179-185
8. Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA 2006 Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling. Contraception 74:297-302
9. Walsh JS, Eastell R, Peel NF 2008 Effects of depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. J Clin Endocrinol Metab 93: 1317-1323
10. Herrmann M, Seibel MJ 2010 The effects of hormonal contraceptives on bone turnover markers and bone health. Clin Endocrinol (Oxf) 72:571-583
11. Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, Camlin-Shingler K, Secic M 2008 Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril 90:2060-2067
12. Beksinska ME, Kleinschmidt I, Smit JA, Farley TM 2007 Bone mineral density in adolescents using norethisterone enanthate, depotmedroxyprogesterone acetate or combined oral contraceptives for contraception. Contraception 75:438-443 (Pubitemid 46766652)
13. Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A 2001 A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 98:576-582
14. Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z 1996 A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 129:671-676
15. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR 1991 Bone density in women receiving depot medroxyprogesterone acetate for contraception. Bmj 303:13-16
16. Lara-Torre E, Edwards CP, Perlman S, Hertweck SP 2004 Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 17:17-21
17. Kaunitz AM, Arias R, McClung M 2008 Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception 77:67-76
18. Curtis KM, Martins SL 2006 Progestogen-only contraception and bone mineral density: a systematic review. Contraception 73:470-487
19. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM 2002 Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 13:581-587
20. Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A 2004 Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol 103:899-906
21. Clark MK, Sowers MR, Nichols S, Levy B 2004 Bone mineral density changes over two years in first-time users of depot medroxy-progesterone acetate. Fertil Steril 82:1580-1586
22. Harkins GJ, Davis GD, Dettori J, Hibbert ML, Hoyt RA 1999 Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report. J Reprod Med 44:309-312
23. Searle ES 2005 Spinal fracture in a young Depo-Provera user. J Fam Plann Reprod Health Care 31:255
24. Watson KC, Lentz MJ, Cain KC 2006 Associations between fracture incidence and use of depot medroxyprogesterone acetate and antiepileptic drugs in women with developmental disabilities. Womens Health Issues 16:346-352
25. Lappe JM, Stegman MR, Recker RR 2001 The impact of lifestyle factors on stress fractures in female Army recruits. Osteoporos Int 12:35-42
26. Vestergaard P, Rejnmark L, Mosekilde L 2008 The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception 78:459-464
27. Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR 2006 Bone mineral density in women aged 25-35 years receiving depot me- droxyprogesterone acetate: recovery following discontinuation. Contraception 74:90-99
28. García Rodríguez LA, Pérez Gutthann S 1998 Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45:419-425
29. Wood L, Martinez C 2004 The general practice research database: role in pharmacovigilance. Drug Saf 27:871-881
30. Jick H, Jick SS, Derby LE 1991 Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302:766-768
31. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodríguez LA, Ruigómez A, Meier CR, Schlienger RG, Black C, Jick H 2003 Validity of the general practice research database. Pharmacotherapy 23:686-689
32. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H 2000 HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283:3205-3210
33. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR 2004 Use of β-blockers and risk of fractures. JAMA 292:1326-1332
34. Meier C, Kraenzlin ME, Bodmer M, Jick SS, Jick H, Meier CR 2008 Use of thiazolidinediones and fracture risk. Arch Intern Med 168: 820-825
35. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C 2000 Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383-1389
36. Vestergaard P, Rejnmark L, Mosekilde L 2004 Fracture risk associated with use of antiepileptic drugs. Epilepsia 45:1330-1337 (Pubitemid 39470036)
37. De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ 3rd, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A 2005 Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330-1338
38. Martins SL, Curtis KM, Glasier AF 2006 Combined hormonal contraception and bone health: a systematic review. Contraception 73: 445-469
39. Lader D, Hopkins G 2008 Contraception and sexual health 2007/ 08. Newport, UK: Office of National Statistics
40. Shawe J, Mulnier H, Nicholls P, Lawrenson R 2008 Use of hormonal contraceptive methods by women with diabetes. Prim Care Diabetes 2:195-199
41. Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE 1999 Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 93:233-238 (Pubitemid 29068099)